Smoothened (Smo) Inhibitor Lde225 Combined With Nilotinib In Patients With Chronic Myeloid Leukemia (Cml) Resistant/Intolerant (R/I) To At Least 1 Prior Tyrosine Kinase Inhibitor: A Phase 1B Study

Authors
Publication date
1 June 2015
Publisher
'Ferrata Storti Foundation (Haematologica)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Online Research @ Cardiff

    redirect
    oaioai:https://orca.cardiff.ac.uk...
    Last time updated on 15/07/2021